Whole kidney engineering for clinical translation

Current Opinion in Organ Transplantation

Volumn 20, Issue 2, 2015, Pages 165-170

  Kim, Ick Hee ^a,b   Ko, In Kap ^a   Atala, Anthony ^a   Yoo, James J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

cell sources; clinical translation; decellularization; kidney scaffolds; long term implantation; recellularization

Indexed keywords

BIOENGINEERING; CULTURE TECHNIQUE; CYTOLOGY; EMBRYONIC STEM CELL; END STAGE RENAL DISEASE; HUMAN; IMPLANTATION; KIDNEY; KIDNEY CELL; KIDNEY TRANSPLANTATION; NANOFABRICATION; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; STEM CELL; ANIMAL; KIDNEY FAILURE, CHRONIC; PHYSIOLOGY; PROCEDURES; TISSUE ENGINEERING; TISSUE SCAFFOLD;

ANIMALS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84930834438     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000173     Document Type: Review

References (42)

1. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013; 382:260-272.
2. National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC). Kidney disease statistics for the United States 2012. http://kidney.niddk.nih. gov/kudiseases/pubs/kustats/. [Accessed 10 October 2014]
3. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008; 14:213-221.
4. Baptista PM, Siddiqui MM, Lozier G, et al. The use of whole organ decel-lularization for the generation of a vascularized liver organoid. Hepatology 2011; 53:604-617.
5. Orlando G, Wood KJ, Stratta RJ, et al. Regenerative medicine and organ transplantation: past, present, and future. Transplantation 2011; 91:1310-1317.
6. Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010; 16:814-820.
7. Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010; 16:927-933.
8. Song JJ, Guyette JP, Gilpin SE, et al. Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med 2013; 19:646-651.
9. Arenas-Herrera JE, Ko IK, Atala A, et al. Decellularization for whole organ bioengineering. Biomed Mater 2013; 8:014106.
10. Ross EA, Abrahamson DR, St John P, et al. Mouse stem cells seeded into decellularized rat kidney scaffolds endothelialize and remodel basement membranes. Organogenesis 2012; 8:49-55.
11. Ross EA, Williams MJ, Hamazaki T, et al. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J Am Soc Nephrol 2009; 20:2338-2347.
12. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials 2011; 32:3233-3243.
13. Yoldas A, Dayan MO. Morphological characteristics of renal artery and kidney in rats. Sci World J 2014; 2014:468982.
14. Johnson S, Rishi R, Andone A, et al. Determinants and functional significance of renal parenchymal volume in adults. Clin J Am Soc Nephrol 2011; 6:70-76.
15. Lawton JS, Moazami N, Pasque MK, et al. Early stenosis of Medtronic Mosaic porcine valves in the aortic position. J Thorac Cardiovasc Surg 2009; 137:1556-1557.
16. Iannotti JP, Codsi MJ, Kwon YW, et al. Porcine small intestine submucosa augmentation of surgical repair of chronic two-tendon rotator cuff tears. A randomized, controlled trial. J Bone Joint Surg Am 2006; 88:1238-1244.
17. Sullivan DC, Mirmalek-Sani SH, Deegan DB, et al. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials 2012; 33:7756-7764.
18. Orlando G, Farney AC, Iskandar SS, et al. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations. Ann Surg 2012; 256:363-370.
19. Park KM, Woo HM. Porcine bioengineered scaffolds as new frontiers in regenerative medicine. Transplant Proc 2012; 44:1146-1150.
20. Wang Y, Bao J, Wu Q, et al. Method for perfusion decellularization of porcine whole liver and kidney for use as a scaffold for clinical-scale bioengineering engrafts. Xenotransplantation 2014; doi: 10.1111/xen.12141. [Epub ahead of print]
21. Orlando G, Booth C, Wang Z, et al. Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies. Biomaterials 2013; 34:5915-5925.
22. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981; 78:7634-7638.
23. Morizane R, Monkawa T, Itoh H. Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro. Biochem Biophys Res Commun 2009; 390:1334-1339.
24. Kim D, Dressler GR. Nephrogenic factors promote differentiation of mouse embryonic stem cells into renal epithelia. J Am Soc Nephrol 2005; 16:3527-3534.
25. Steenhard BM, Isom KS, Cazcarro P, et al. Integrationofembryonic stem cells in metanephric kidney organ culture. J Am Soc Nephrol 2005; 16:1623-1631.
26. Vigneau C, Polgar K, Striker G, et al. Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol 2007; 18:1709-1720.
27. Nakayama KH, Lee CC, Batchelder CA, et al. Tissue specificity of decel-lularized rhesus monkey kidney and lung scaffolds. PLoS One 2013; 8:e64134.
28. Bonandrini B, Figliuzzi M, Papadimou E, et al. Recellularization of well preserved acellular kidney scaffold using embryonic stem cells. Tissue Eng, Part A 2014; 20:1486-1498.
29. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126:663-676.
30. Ren X, Zhang J, Gong X, et al. Differentiation of murine embryonic stem cells toward renal lineages by conditioned medium from ureteric bud cells in vitro. Acta Biochim Biophys Sin (Shanghai) 2010; 42:464-471.
31. Lam AQ, Freedman BS, Bonventre JV. Directed differentiation of pluripotent stem cells to kidney cells. Semin Nephrol 2014; 34:445-461.
32. Song B, Niclis JC, Alikhan MA, et al. Generation of induced pluripotent stem cells from human kidney mesangial cells. J Am Soc Nephrol 2011; 22:1213-1220.
33. Zhou T, Benda C, Dunzinger S, et al. Generationofhuman induced pluripotent stem cells from urine samples. Nat Protoc 2012; 7:2080-2089.
34. Freedman BS, Lam AQ, Sundsbak JL, et al. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J Am Soc Nephrol 2013; 24:1571-1586.
35. Wakitani S, Takaoka K, Hattori T, et al. Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. Rheumatology (Oxford) 2003; 42:162-165.
36. Guimaraes-Souza NK, Yamaleyeva LM, Abou Shwareb T, et al. In vitro reconstitution of human kidney structures for renal cell therapy. Nephrol, Dial, Transplant: Off Publ Eur Dial Transplant Assoc-Eur Renal Assoc 2012; 27:3082-3090.
37. Yamaleyeva LM, Guimaraes-Souza NK, Krane LS, et al. Cell therapy with human renal cell cultures containing erythropoietin-positive cells improves chronic kidney injury. Stem Cells Transl Med 2012; 1:373-383.
38. Presnell SC, Bruce AT, Wallace SM, et al. Isolation, characterization, and expansion methods for defined primary renal cell populations from rodent, canine, and human normal and diseased kidneys. Tissue Eng Part C, Methods 2011; 17:261-273.
39. Baer PC, Geiger H. Human renal cells from the thick ascending limb and early distal tubule: characterization of primary isolated and cultured cells by reverse transcription polymerase chain reaction. Nephrology 2008; 13:316-321.
40. Petersen TH, Calle EA, Zhao L, et al. Tissue-engineered lungs for in vivo implantation. Science 2010; 329:538-541.
41. Ko IK, Abolbashari M, Huling J, et al. Enhanced Rre-endothelialization of acellular kidney scaffolds for whole organ engineering via antibody conjugation of vasculatures. Technology 2014; 2:243-253.
42. Arbiser JL, Moses MA, Fernandez CA, et al. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA 1997; 94:861-866.